Finance

Lists
Why is SPARC down 2,75%?
Dive Deeper
SPARC:NSE
Sun Pharma Advanced Research Co Ltd
206,50 INR
-2,75%
(-5,85) 1D
13 ნოე, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SPARC...
Open
212,35 INR
High
213,09 INR
Low
204,00 INR
Mkt. cap
67,01 მლრდ.
Avg. vol.
1,97 მლნ.
Volume
1,04 მლნ.
P/E ratio
4,09
52-wk high
289,00 INR
52-wk low
108,00 INR
EPS
50,50 INR
Shares outstanding
255,99 მლნ.
No. of employees
279
Open
212,35 INR
High
213,09 INR
Low
204,00 INR
Mkt. cap
67,01 მლრდ.
Avg. vol.
1,97 მლნ.
Volume
1,04 მლნ.
P/E ratio
4,09
52-wk high
289,00 INR
52-wk low
108,00 INR
EPS
50,50 INR
Shares outstanding
255,99 მლნ.
No. of employees
279
News stories
From web sources and news partners
Northwood University
Northwood University
·
47 წუთის წინ
Former NYSE Vice Chairman Encourages Students to Build Relationships, Embrace Change
bloomingbit
bloomingbit
·
5 წუთის წინ
U.S. Stocks End Mixed; Nasdaq Falls 0.91%
CNBC
CNBC
·
3 საათის წინ
Is a bottom in for the Nasdaq-100? Charts to watch
Reuters
Reuters
·
6 საათის წინ
Goldman Sachs sees S&P 500 rising to 8,700 next year despite slower earnings growth
About Sun Pharma Advanced Research Co Ltd
CEO-
Employees279
Founded2006
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitesparc.life
Last report
2 ნოე. 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
300,30 მლნ. / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
84,50 მლნ.
18,53 მლრდ.
399,20 მლნ.
300,30 მლნ.
Cost of goods sold
72,10 მლნ.
115,06 მლნ.
76,60 მლნ.
99,50 მლნ.
Cost of revenue
72,10 მლნ.
115,06 მლნ.
76,60 მლნ.
99,50 მლნ.
Research and development expenses
62,70 მლნ.
28,44 მლნ.
132,60 მლნ.
92,50 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
424,60 მლნ.
557,37 მლნ.
448,00 მლნ.
448,50 მლნ.
Operating expense
604,50 მლნ.
605,33 მლნ.
684,60 მლნ.
678,90 მლნ.
Total operating expenses
676,60 მლნ.
720,39 მლნ.
761,20 მლნ.
778,40 მლნ.
Operating income
-592,10 მლნ.
17,81 მლრდ.
-362,00 მლნ.
-478,10 მლნ.
Other non operating income
-
-116,03 მლნ.
236,60 მლნ.
236,20 მლნ.
EBT including unusual items
-803,50 მლნ.
17,61 მლრდ.
-206,70 მლნ.
-243,10 მლნ.
EBT excluding unusual items
-679,90 მლნ.
17,61 მლრდ.
-206,70 მლნ.
-243,10 მლნ.
Income tax expense
700,00 ათ.
-3,84 მლნ.
1,10 მლნ.
800,00 ათ.
Effective tax rate
-0,09%
-0,02%
-0,53%
-0,33%
Other operating expenses
91,50 მლნ.
-3,44 მლნ.
82,00 მლნ.
115,90 მლნ.
Net income
-804,20 მლნ.
17,61 მლრდ.
-207,80 მლნ.
-243,90 მლნ.
Net profit margin
-951,72%
95,04%
-52,05%
-81,22%
Earnings per share
-
-
-
-
Interest and investment income
-
102,87 მლნ.
-
-
Interest expense
-87,80 მლნ.
-90,07 მლნ.
-81,30 მლნ.
-1,20 მლნ.
Net interest expenses
-87,80 მლნ.
12,80 მლნ.
-81,30 მლნ.
-1,20 მლნ.
Depreciation and amortization charges
25,70 მლნ.
22,96 მლნ.
22,00 მლნ.
22,00 მლნ.
EBITDA
-570,75 მლნ.
17,83 მლრდ.
-342,34 მლნ.
-456,10 მლნ.
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები